T1	tradename 112 120	TRIGLIDE
T2	tradename 183 202	TRIGLIDE. TRIGLIDE
T3	activeingredient 204 216	fenofibrate)
T4	routeofadministration 230 234	oral
T5	fdaapprovaldate 262 266	1993
T6	tradename 345 353	Triglide
T7	indication 562 582	hypercholesterolemia
T8	indication 592 605	dyslipidemia.
T9	indication 690 711	hypertriglyceridemia.
T10	activeingredient 743 754	Fenofibrate
T11	indication 1017 1037	hypertriglyceridemia
T12	indication 1048 1061	dyslipidemia:
T13	dose 1062 1068	160 mg
T14	frequency 1069 1076	per day
T15	indication 1100 1121	Hypertriglyceridemia:
T16	dose 1121 1133	50 to 160 mg
T17	frequency 1134 1142	per day;
T18	dose 1260 1265	50 mg
T19	frequency 1266 1273	per day
T20	activeingredient 1781 1792	fenofibrate
T21	adversereaction 1880 1888	Myopathy
T22	adversereaction 1893 1907	rhabdomyolysis
T23	activeingredient 1946 1958	fenofibrate.
T24	adversereaction 1981 1996	muscle toxicity
T25	activeingredient 2122 2133	Fenofibrate
T26	adversereaction 2138 2167	increase serum transaminases.
T27	activeingredient 2250 2261	Fenofibrate
T28	adversereaction 2273 2307	increases serum creatinine levels.
T29	activeingredient 2394 2405	Fenofibrate
T30	adversereaction 2472 2487	cholelithiasis.
T31	adversereaction 2491 2505	cholelithiasis
T32	co-administereddrug 2618 2642	coumarin anticoagulants.
T33	adversereaction 2924 2990	abnormal liver tests, increased AST, increased ALT, increased CPK,
T34	adversereaction 2995 3004	rhinitis.
T35	company 3059 3067	Shionogi
T36	indication 3810 3830	Hypercholesterolemia
T37	indication 3840 3852	Dyslipidemia
T38	indication 3865 3885	Hypertriglyceridemia
T39	indication 3991 4011	Hypercholesterolemia
T40	indication 4021 4033	Dyslipidemia
T41	indication 4046 4066	Hypertriglyceridemia
T42	indication 5150 5170	Hypercholesterolemia
T43	indication 5222 5234	Dyslipidemia
T44	indication 5562 5582	Hypercholesterolemia
T45	indication 5592 5604	Dyslipidemia
T46	tradename 5606 5614	Triglide
T47	indication 5888 5908	hypercholesterolemia
T48	indication 5918 5931	dyslipidemia.
T49	indication 5945 5965	Hypertriglyceridemia
T50	tradename 5966 5974	Triglide
T51	indication 6068 6089	hypertriglyceridemia.
T52	activeingredient 6440 6451	fenofibrate
T53	activeingredient 6549 6560	Fenofibrate
T54	tradename 6891 6900	Triglide,
T55	tradename 6953 6971	Triglide. Triglide
T56	tradename 7056 7064	Triglide
T57	indication 7147 7159	dyslipidemia
T58	indication 7304 7324	hypertriglyceridemia
T59	indication 7458 7479	hypercholesterolemia,
T60	indication 7731 7752	hypertriglyceridemia.
T61	indication 7866 7887	hypertriglyceridemia.
T62	tradename 7995 8003	Triglide
T63	dose 8209 8215	160 mg
T64	frequency 8216 8227	once daily.
T65	indication 8242 8262	Hypercholesterolemia
T66	indication 8272 8284	Dyslipidemia
T67	tradename 8297 8305	Triglide
T68	dose 8309 8315	160 mg
T69	frequency 8316 8327	once daily.
T70	indication 8340 8360	Hypertriglyceridemia
T71	dose 8381 8393	50 to 160 mg
T72	frequency 8394 8402	per day.
T73	dose 8587 8593	160 mg
T74	frequency 8594 8605	once daily.
T75	tradename 8650 8658	Triglide
T76	dose 8692 8697	50 mg
T77	frequency 8698 8705	per day
T78	tradename 8975 8983	Triglide
T79	tradename 9518 9526	Triglide
T80	activeingredient 10006 10017	fenofibrate
T81	tradename 10238 10246	Triglide
T82	activeingredient 10569 10581	fenofibrate.
T83	activeingredient 10628 10639	Fenofibrate
T84	activeingredient 11344 11355	Fenofibrate
T85	activeingredient 11525 11549	fenofibrate. Fenofibrate
T86	activeingredient 12016 12027	fenofibrate
T87	tradename 12125 12133	Triglide
T88	activeingredient 12135 12146	fenofibrate
T89	tradename 12315 12324	Triglide.
T90	activeingredient 14644 14656	Fenofibrates
T91	adversereaction 14678 14686	myopathy
T92	adversereaction 14717 14732	rhabdomyolysis.
T93	adversereaction 14755 14770	muscle toxicity
T94	adversereaction 14946 14960	rhabdomyolysis
T95	co-administereddrug 15044 15081	HMG-CoA reductase inhibitor (statin).
T96	adversereaction 15277 15285	Myopathy
T97	tradename 15658 15666	Triglide
T98	adversereaction 15739 15756	myopathy/myositis
T99	adversereaction 15781 15790	myopathy,
T100	adversereaction 15801 15816	rhabdomyolysis,
T101	activeingredient 15841 15853	fenofibrates
T102	co-administereddrug 15874 15885	colchicine,
T103	activeingredient 15935 15946	fenofibrate
T104	co-administereddrug 15952 15962	colchicine
T105	activeingredient 16015 16026	Fenofibrate
T106	adversereaction 16031 16060	increase serum transaminases
T107	activeingredient 16237 16248	fenofibrate
T108	adversereaction 16482 16508	increases in transaminases
T109	activeingredient 16520 16531	fenofibrate
T110	dose 16741 16747	134 mg
T111	dose 16751 16757	200 mg
T112	activeingredient 16758 16769	fenofibrate
T113	frequency 16770 16777	per day
T114	dose 16807 16813	160 mg
T115	tradename 16814 16823	Triglide)
T116	dose 16876 16881	34 mg
T117	dose 16885 16890	67 mg
T118	activeingredient 16902 16913	fenofibrate
T119	frequency 16914 16922	per day,
T120	activeingredient 17099 17110	fenofibrate
T121	tradename 17405 17413	Triglide
T122	adversereaction 17523 17550	Serum Creatinine Elevations
T123	activeingredient 17605 17617	fenofibrate.
T124	activeingredient 17692 17704	fenofibrate.
T125	tradename 17829 17838	Triglide.
T126	tradename 17903 17911	Triglide
T127	adversereaction 17997 18011	Cholelithiasis
T128	activeingredient 18012 18024	Fenofibrate,
T129	adversereaction 18120 18135	cholelithiasis.
T130	adversereaction 18139 18153	cholelithiasis
T131	tradename 18203 18211	Triglide
T132	co-administereddrug 18273 18296	Coumarin Anticoagulants
T133	tradename 18375 18383	Triglide
T134	co-administereddrug 18416 18444	coumarin-type anti-coagulant
T135	adversereaction 18811 18836	Pancreatitis Pancreatitis
T136	activeingredient 18874 18886	fenofibrate,
T137	indication 18993 19014	hypertriglyceridemia,
T138	adversereaction 19167 19186	Hematologic Changes
T139	activeingredient 19315 19326	fenofibrate
T140	activeingredient 19485 19497	fenofibrate.
T141	tradename 19592 19600	Triglide
T142	adversereaction 19622 19648	Hypersensitivity Reactions
T143	adversereaction 19655 19681	hypersensitivity reactions
T144	adversereaction 19690 19715	Stevens-Johnson syndrome,
T145	adversereaction 19720 19746	toxic epidermal necrolysis
T146	activeingredient 19857 19870	fenofibrates.
T147	adversereaction 19872 19881	Urticaria
T148	adversereaction 19910 19914	rash
T149	activeingredient 19934 19945	fenofibrate
T150	adversereaction 20008 20034	Venothromboembolic Disease
T151	activeingredient 20147 20159	fenofibrate-
T152	activeingredient 20284 20295	fenofibrate
T153	activeingredient 20378 20389	fenofibrate
T154	activeingredient 20489 20500	fenofibrate
T155	activeingredient 22196 22207	fenofibrate
T156	activeingredient 22392 22403	fenofibrate
T157	activeingredient 22530 22541	fenofibrate
T158	activeingredient 22672 22683	Fenofibrate
T159	activeingredient 22791 22803	Fenofibrate*
T160	adversereaction 22849 22863	Abdominal Pain
T161	adversereaction 22877 22886	Back Pain
T162	adversereaction 22900 22908	Headache
T163	adversereaction 22933 22939	Nausea
T164	adversereaction 22953 22965	Constipation
T165	adversereaction 23016 23036	Abnormal Liver Tests
T166	adversereaction 23052 23065	Increased AST
T167	adversereaction 23081 23094	Increased ALT
T168	adversereaction 23108 23140	Increased Creatine Phosphokinase
T169	adversereaction 23166 23186	Respiratory Disorder
T170	adversereaction 23200 23208	Rhinitis
T171	dose 23244 23250	200 mg
T172	activeingredient 23251 23262	fenofibrate
T173	dose 23306 23312	160 mg
T174	tradename 23313 23322	Triglide.
T175	activeingredient 23474 23486	fenofibrate:
T176	adversereaction 23487 23614	myalgia, rhabdomyolysis, pancreatitis, muscle spasms, acute renal failure, hepatitis, cirrhosis, anemia, arthralgia, asthenia,
T177	adversereaction 23619 23661	severely depressed HDL-cholesterol levels.
T178	co-administereddrug 23988 24011	Coumarin Anticoagulants
T179	co-administereddrug 24029 24056	coumarin-type anticoagulant
T180	co-administereddrug 24150 24173	coumarin anticoagulants
T181	tradename 24204 24213	Triglide.
T182	co-administereddrug 24503 24540	Immunosuppressants Immunosuppressants
T183	co-administereddrug 24549 24561	cyclosporine
T184	co-administereddrug 24566 24576	tacrolimus
T185	adversereaction 24589 24603	nephrotoxicity
T186	tradename 24763 24772	Triglide,
T187	tradename 24887 24895	Triglide
T188	co-administereddrug 24901 24919	immunosuppressants
T189	co-administereddrug 25067 25091	Bile-Acid Binding Resins
T190	co-administereddrug 25098 25122	bile acid binding resins
T191	tradename 25185 25193	Triglide
T192	co-administereddrug 25242 25265	bile acid binding resin
T193	co-administereddrug 25305 25315	Colchicine
T194	adversereaction 25326 25335	myopathy,
T195	adversereaction 25346 25361	rhabdomyolysis,
T196	activeingredient 25386 25398	fenofibrates
T197	co-administereddrug 25420 25431	colchicine,
T198	activeingredient 25481 25492	fenofibrate
T199	co-administereddrug 25498 25509	colchicine.
T200	activeingredient 25683 25694	fenofibrate
T201	activeingredient 25714 25725	Fenofibrate
T202	routeofadministration 25853 25857	oral
T203	dose 25875 25896	15, 75, and 300 mg/kg
T204	frequency 25896 25900	/day
T205	activeingredient 25904 25915	fenofibrate
T206	routeofadministration 26121 26125	oral
T207	dose 26143 26165	14, 127, and 361 mg/kg
T208	frequency 26165 26169	/day
T209	dose 26282 26291	14 mg/kg/
T210	frequency 26291 26294	day
T211	routeofadministration 26478 26482	oral
T212	dose 26499 26521	15, 150, and 300 mg/kg
T213	frequency 26521 26525	/day
T214	dose 26642 26651	150 mg/kg
T215	frequency 26651 26655	/day
T216	dose 26767 26775	15 mg/kg
T217	frequency 26775 26779	/day
T218	routeofadministration 26884 26888	oral
T219	dose 26906 26927	15, 75, and 300 mg/kg
T220	frequency 26927 26931	/day
T221	activeingredient 27199 27210	Fenofibrate
T222	tradename 28098 28107	Triglide.
T223	tradename 28141 28149	Triglide
T224	tradename 28501 28509	Triglide
T225	tradename 28696 28705	Triglide.
T226	activeingredient 29019 29030	fenofibrate
T227	tradename 29123 29131	Triglide
T228	activeingredient 29133 29145	fenofibrate)
T229	routeofadministration 29208 29212	oral
T230	activeingredient 29269 29281	fenofibrate.
T231	activeingredient 29304 29315	fenofibrate
T232	molecularweight 29500 29507	360.83;
T233	activeingredient 29508 29519	fenofibrate
T234	activeingredient 29575 29586	Fenofibrate
T235	inactiveingredient 29790 29986	crospovidone, lactose monohydrate, mannitol, maltodextrin, carboxymethylcellulose sodium, egg lecithin, croscarmellose sodium, sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate,
T236	inactiveingredient 29991 30018	monobasic sodium phosphate.
T237	tradename 30092 30100	Triglide
T238	routeofadministration 30233 30237	oral
T239	activeingredient 30256 30268	fenofibrate.
T240	activeingredient 30531 30542	fenofibrate
T241	activeingredient 31181 31192	Fenofibrate
T242	activeingredient 32038 32050	fenofibrate,
T243	activeingredient 32238 32249	fenofibrate
T244	tradename 32364 32372	Triglide
T245	dose 32373 32379	160 mg
T246	dose 32452 32458	200 mg
T247	activeingredient 32459 32470	fenofibrate
T248	activeingredient 32493 32504	Fenofibrate
T249	activeingredient 32567 32578	Fenofibrate
T250	activeingredient 32751 32762	fenofibrate
T251	activeingredient 32864 32875	Fenofibrate
T252	activeingredient 32973 32984	fenofibrate
T253	activeingredient 32999 33010	fenofibrate
T254	routeofadministration 33072 33076	oral
T255	activeingredient 33167 33178	fenofibrate
T256	tmax 33351 33358	3 hours
T257	tradename 33410 33418	Triglide
T258	tradename 33516 33524	Triglide
T259	activeingredient 34059 34070	Fenofibrate
T260	co-administereddrug 34127 34139	Atorvastatin
T261	dose 34142 34147	20 mg
T262	frequency 34148 34170	once daily for 10 days
T263	activeingredient 34174 34185	Fenofibrate
T264	dose 34186 34192	160 mg
T265	routeofadministration 34257 34261	oral
T266	activeingredient 34278 34289	fenofibrate
T267	activeingredient 34381 34392	fenofibrate
T268	activeingredient 34720 34731	fenofibrate
T269	activeingredient 34863 34874	fenofibrate
T270	activeingredient 35032 35044	fenofibrate,
T271	eliminationhalflife 35197 35206	16 hours,
T272	routeofadministration 35350 35354	oral
T273	activeingredient 35363 35374	fenofibrate
T274	clearance 35379 35387	1.2 L/h,
T275	clearance 35406 35413	1.1 L/h
T276	tradename 35674 35682	Triglide
T277	activeingredient 35814 35826	fenofibrate.
T278	activeingredient 35884 35895	fenofibrate
T279	activeingredient 35927 35938	fenofibrate
T280	tradename 36729 36737	Triglide
T281	activeingredient 37117 37128	fenofibrate
T282	activeingredient 37496 37507	fenofibrate
T283	activeingredient 37619 37630	Fenofibrate
T284	co-administereddrug 37797 37808	Pravastatin
T285	dose 37809 37814	40 mg
T286	co-administereddrug 37833 37844	Fluvastatin
T287	dose 37845 37850	40 mg
T288	co-administereddrug 37891 37902	Glimepiride
T289	dose 37903 37907	1 mg
T290	co-administereddrug 37926 37935	Metformin
T291	dose 37936 37942	850 mg
T292	frequency 37943 37972	three times daily for 10 days
T293	co-administereddrug 37974 37987	Rosiglitazone
T294	dose 37988 37992	8 mg
T295	frequency 37993 38014	once daily for 5 days
T296	activeingredient 38026 38038	fenofibrate)
T297	activeingredient 38062 38074	fenofibrate)
T298	frequency 38101 38123	once daily for 10 days
T299	activeingredient 38125 38136	Fenofibrate
T300	activeingredient 38206 38217	Fenofibrate
T301	dose 38218 38225	160 mg1
T302	activeingredient 38285 38296	Fenofibrate
T303	dose 38297 38304	145 mg1
T304	frequency 38306 38328	once daily for 10 days
T305	activeingredient 38368 38379	Fenofibrate
T306	dose 38380 38386	54 mg1
T307	frequency 38388 38417	three times daily for 10 days
T308	activeingredient 38458 38469	Fenofibrate
T309	dose 38470 38477	145 mg1
T310	frequency 38479 38501	once daily for 14 days
T311	activeingredient 38562 38573	Fenofibrate
T312	activeingredient 38698 38709	Fenofibrate
T313	activeingredient 38772 38783	Fenofibrate
T314	dose 38784 38791	160 mg1
T315	frequency 38792 38814	once daily for 10 days
T316	activeingredient 38816 38827	Fenofibrate
T317	activeingredient 38858 38869	Fenofibrate
T318	dose 38870 38877	160 mg1
T319	activeingredient 38919 38930	Fenofibrate
T320	dose 38931 38938	145 mg1
T321	frequency 38939 38961	once daily for 10 days
T322	activeingredient 38963 38974	Fenofibrate
T323	dose 38975 38981	54 mg1
T324	frequency 38982 39012	three times daily for 10 days
T325	activeingredient 39014 39025	Fenofibrate
T326	dose 39026 39033	145 mg1
T327	frequency 39034 39056	once daily for 14 days
T328	co-administereddrug 39058 39071	Atorvastatin,
T329	dose 39072 39077	20 mg
T330	frequency 39078 39100	once daily for 10 days
T331	co-administereddrug 39102 39114	Pravastatin,
T332	dose 39115 39120	40 mg
T333	co-administereddrug 39139 39151	Fluvastatin,
T334	dose 39152 39157	40 mg
T335	co-administereddrug 39176 39188	Glimepiride,
T336	dose 39189 39193	1 mg
T337	co-administereddrug 39212 39222	Metformin,
T338	dose 39223 39229	850 mg
T339	frequency 39230 39259	three times daily for 10 days
T340	co-administereddrug 39261 39275	Rosiglitazone,
T341	dose 39276 39280	8 mg
T342	frequency 39281 39302	once daily for 5 days
T343	co-administereddrug 39304 39316	Atorvastatin
T344	co-administereddrug 39341 39352	Pravastatin
T345	co-administereddrug 39394 39420	3-Hydroxyl-iso-pravastatin
T346	co-administereddrug 39469 39483	5S-Fluvastatin
T347	co-administereddrug 39525 39536	Glimepiride
T348	co-administereddrug 39578 39587	Metformin
T349	co-administereddrug 39627 39640	Rosiglitazone
T350	activeingredient 39689 39701	fenofibrate)
T351	routeofadministration 39702 39706	oral
T352	activeingredient 39724 39736	fenofibrate)
T353	routeofadministration 39737 39741	oral
T354	activeingredient 39988 40000	fenofibrate.
T355	activeingredient 40059 40070	fenofibrate
T356	dose 40074 40094	10, 45 and 200 mg/kg
T357	frequency 40094 40099	/day,
T358	dose 40238 40247	200 mg/kg
T359	frequency 40247 40251	/day
T360	dose 40669 40684	10 and 60 mg/kg
T361	frequency 40684 40688	/day
T362	activeingredient 40970 40981	fenofibrate
T363	dose 40982 40997	10 and 60 mg/kg
T364	frequency 40997 41001	/day
T365	dose 41042 41052	400 mg/kg;
T366	dose 41095 41105	250 mg/kg;
T367	activeingredient 41161 41172	Fenofibrate
T368	activeingredient 41508 41519	fenofibrate
T369	dose 41520 41540	10, 45 and 200 mg/kg
T370	frequency 41540 41544	/day
T371	dose 41736 41756	10, 60 and 200 mg/kg
T372	frequency 41756 41761	/day,
T373	activeingredient 41762 41773	fenofibrate
T374	activeingredient 41970 41981	fenofibrate
T375	activeingredient 42327 42338	Fenofibrate
T376	routeofadministration 42587 42591	oral
T377	activeingredient 42609 42621	fenofibrate,
T378	dose 42777 42786	300 mg/kg
T379	frequency 42786 42790	/day
T380	indication 42904 42924	Hypercholesterolemia
T381	indication 42976 42988	Dyslipidemia
T382	activeingredient 43005 43016	fenofibrate
T383	tradename 43041 43049	Triglide
T384	dose 43050 43056	160 mg
T385	frequency 43057 43064	per day
T386	activeingredient 43309 43320	Fenofibrate
T387	activeingredient 43380 43391	Fenofibrate
T388	activeingredient 44523 44534	Fenofibrate
T389	indication 44697 44717	Hypertriglyceridemia
T390	activeingredient 44733 44744	fenofibrate
T391	indication 45113 45133	hypertriglyceridemia
T392	activeingredient 45214 45225	fenofibrate
T393	dose 45251 45257	160 mg
T394	tradename 45258 45266	Triglide
T395	frequency 45267 45274	per day
T396	activeingredient 45597 45608	Fenofibrate
T397	indication 45633 45653	Hypertriglyceridemia
T398	activeingredient 45670 45682	Fenofibrate*
T399	activeingredient 46139 46151	Fenofibrate*
T400	tradename 46650 46658	Triglide
T401	tradename 46674 46682	Triglide
T402	tradename 47301 47310	Triglide.
T403	tradename 47332 47340	Triglide
T404	activeingredient 47381 47392	fenofibrate
T405	tradename 47483 47492	Triglide.
T406	tradename 47596 47604	Triglide
T407	tradename 47926 47935	Triglide.
T408	tradename 48016 48025	Triglide.
T409	tradename 48043 48051	Triglide
T410	company 48340 48353	Shionogi Inc.
T411	company 48402 48415	Shionogi Inc.
